A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens

Haruhiko Kashiwazaki, Takae Matsushita, Junichi Sugita, Akio Shigematsu, Kumiko Kasashi, Yutaka Yamazaki, Takashi Kanehira, Takeshi Kondo, Tomoyuki Endo, Junji Tanaka, Satoshi Hashino, Mitsufumi Nishio, Masahiro Imamura, Yoshimasa Kitagawa, Nobuo Inoue

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Severe oral mucositis developed in allogeneic hematopoietic stem cell transplantation (HSCT) accompanies intolerable pain and risk for systemic bacteremia infection. Conventional stem cell transplantation (CST) and reduced-intensity regimens for allogeneic HSCT (RIST) may differently affect the occurrence and severity of oral mucositis. Here, we comparatively examined oral mucositis in patients undergoing CST and that in RIST patients to search for measures to alleviate oral mucositis. We retrospectively analyzed the data of 130 consecutive patients undergoing HSCT (conventional, 60; RIST, 70). Oral mucositis was evaluated according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. We also investigated the risk factors for severe oral mucositis in each regimen. The incidence of oral mucositis was not significantly different between RIST and CST patients. The use of opioid analgesics to control pain due to oral mucositis was significantly less in patients undergoing RIST compared with those receiving CST. The risk factors for severe oral mucositis, determined by univariate and multivariate analyses, were "younger age (<40)" in CST and "longer duration of neutropenia (≥14 days)" in RIST. Although the incidences of oral mucositis were almost the same, the need for opioid analgesics and the risk factors for severe oral mucositis differed between CST and RIST patients.

Original languageEnglish
Pages (from-to)933-939
Number of pages7
JournalSupportive Care in Cancer
Volume20
Issue number5
DOIs
Publication statusPublished - May 1 2012

Fingerprint

Stomatitis
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Opioid Analgesics
Pain
National Cancer Institute (U.S.)
Incidence
Bacteremia
Neutropenia
Terminology
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. / Kashiwazaki, Haruhiko; Matsushita, Takae; Sugita, Junichi; Shigematsu, Akio; Kasashi, Kumiko; Yamazaki, Yutaka; Kanehira, Takashi; Kondo, Takeshi; Endo, Tomoyuki; Tanaka, Junji; Hashino, Satoshi; Nishio, Mitsufumi; Imamura, Masahiro; Kitagawa, Yoshimasa; Inoue, Nobuo.

In: Supportive Care in Cancer, Vol. 20, No. 5, 01.05.2012, p. 933-939.

Research output: Contribution to journalReview article

Kashiwazaki, H, Matsushita, T, Sugita, J, Shigematsu, A, Kasashi, K, Yamazaki, Y, Kanehira, T, Kondo, T, Endo, T, Tanaka, J, Hashino, S, Nishio, M, Imamura, M, Kitagawa, Y & Inoue, N 2012, 'A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens', Supportive Care in Cancer, vol. 20, no. 5, pp. 933-939. https://doi.org/10.1007/s00520-011-1164-2
Kashiwazaki, Haruhiko ; Matsushita, Takae ; Sugita, Junichi ; Shigematsu, Akio ; Kasashi, Kumiko ; Yamazaki, Yutaka ; Kanehira, Takashi ; Kondo, Takeshi ; Endo, Tomoyuki ; Tanaka, Junji ; Hashino, Satoshi ; Nishio, Mitsufumi ; Imamura, Masahiro ; Kitagawa, Yoshimasa ; Inoue, Nobuo. / A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. In: Supportive Care in Cancer. 2012 ; Vol. 20, No. 5. pp. 933-939.
@article{084bf31e501342f6a8d057b78f516de1,
title = "A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens",
abstract = "Severe oral mucositis developed in allogeneic hematopoietic stem cell transplantation (HSCT) accompanies intolerable pain and risk for systemic bacteremia infection. Conventional stem cell transplantation (CST) and reduced-intensity regimens for allogeneic HSCT (RIST) may differently affect the occurrence and severity of oral mucositis. Here, we comparatively examined oral mucositis in patients undergoing CST and that in RIST patients to search for measures to alleviate oral mucositis. We retrospectively analyzed the data of 130 consecutive patients undergoing HSCT (conventional, 60; RIST, 70). Oral mucositis was evaluated according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. We also investigated the risk factors for severe oral mucositis in each regimen. The incidence of oral mucositis was not significantly different between RIST and CST patients. The use of opioid analgesics to control pain due to oral mucositis was significantly less in patients undergoing RIST compared with those receiving CST. The risk factors for severe oral mucositis, determined by univariate and multivariate analyses, were {"}younger age (<40){"} in CST and {"}longer duration of neutropenia (≥14 days){"} in RIST. Although the incidences of oral mucositis were almost the same, the need for opioid analgesics and the risk factors for severe oral mucositis differed between CST and RIST patients.",
author = "Haruhiko Kashiwazaki and Takae Matsushita and Junichi Sugita and Akio Shigematsu and Kumiko Kasashi and Yutaka Yamazaki and Takashi Kanehira and Takeshi Kondo and Tomoyuki Endo and Junji Tanaka and Satoshi Hashino and Mitsufumi Nishio and Masahiro Imamura and Yoshimasa Kitagawa and Nobuo Inoue",
year = "2012",
month = "5",
day = "1",
doi = "10.1007/s00520-011-1164-2",
language = "English",
volume = "20",
pages = "933--939",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens

AU - Kashiwazaki, Haruhiko

AU - Matsushita, Takae

AU - Sugita, Junichi

AU - Shigematsu, Akio

AU - Kasashi, Kumiko

AU - Yamazaki, Yutaka

AU - Kanehira, Takashi

AU - Kondo, Takeshi

AU - Endo, Tomoyuki

AU - Tanaka, Junji

AU - Hashino, Satoshi

AU - Nishio, Mitsufumi

AU - Imamura, Masahiro

AU - Kitagawa, Yoshimasa

AU - Inoue, Nobuo

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Severe oral mucositis developed in allogeneic hematopoietic stem cell transplantation (HSCT) accompanies intolerable pain and risk for systemic bacteremia infection. Conventional stem cell transplantation (CST) and reduced-intensity regimens for allogeneic HSCT (RIST) may differently affect the occurrence and severity of oral mucositis. Here, we comparatively examined oral mucositis in patients undergoing CST and that in RIST patients to search for measures to alleviate oral mucositis. We retrospectively analyzed the data of 130 consecutive patients undergoing HSCT (conventional, 60; RIST, 70). Oral mucositis was evaluated according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. We also investigated the risk factors for severe oral mucositis in each regimen. The incidence of oral mucositis was not significantly different between RIST and CST patients. The use of opioid analgesics to control pain due to oral mucositis was significantly less in patients undergoing RIST compared with those receiving CST. The risk factors for severe oral mucositis, determined by univariate and multivariate analyses, were "younger age (<40)" in CST and "longer duration of neutropenia (≥14 days)" in RIST. Although the incidences of oral mucositis were almost the same, the need for opioid analgesics and the risk factors for severe oral mucositis differed between CST and RIST patients.

AB - Severe oral mucositis developed in allogeneic hematopoietic stem cell transplantation (HSCT) accompanies intolerable pain and risk for systemic bacteremia infection. Conventional stem cell transplantation (CST) and reduced-intensity regimens for allogeneic HSCT (RIST) may differently affect the occurrence and severity of oral mucositis. Here, we comparatively examined oral mucositis in patients undergoing CST and that in RIST patients to search for measures to alleviate oral mucositis. We retrospectively analyzed the data of 130 consecutive patients undergoing HSCT (conventional, 60; RIST, 70). Oral mucositis was evaluated according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. We also investigated the risk factors for severe oral mucositis in each regimen. The incidence of oral mucositis was not significantly different between RIST and CST patients. The use of opioid analgesics to control pain due to oral mucositis was significantly less in patients undergoing RIST compared with those receiving CST. The risk factors for severe oral mucositis, determined by univariate and multivariate analyses, were "younger age (<40)" in CST and "longer duration of neutropenia (≥14 days)" in RIST. Although the incidences of oral mucositis were almost the same, the need for opioid analgesics and the risk factors for severe oral mucositis differed between CST and RIST patients.

UR - http://www.scopus.com/inward/record.url?scp=84863441963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863441963&partnerID=8YFLogxK

U2 - 10.1007/s00520-011-1164-2

DO - 10.1007/s00520-011-1164-2

M3 - Review article

C2 - 21494780

AN - SCOPUS:84863441963

VL - 20

SP - 933

EP - 939

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 5

ER -